Group items tagged

The Innovative Medicines Initiative (IMI) is a European initiative to improve the competitive situation of the European Union in the field of pharmaceutical research. The IMI is a joint initiative (Public-Private Partnership) of the DG Research of the European Commission, representing the European Communities, and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

BudgetOverall: 2 billion EUR

A European Technology Platform (ETP) is a European network bringing together researchers, industry and other relevant stakeholders in a particular technological field in order to foster European research and development in the concerned area.

In a first phase, stakeholders of a specific area, led by industry, come together to agree on a common vision. The second phase is the defining of a Strategic Research Agenda, setting out the medium- to long-term objectives for the technology. In a third phase, stakeholders implement the Strategic Research Agenda with the mobilisation of significant financial and human resources.